MedTrace Logo

Prehospital Management of Stroke Patients by Emergency Medical Services

NCT02191514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2653

Last updated 2016-01-05

No results posted yet for this study

Summary

Annually 12.000 people i Denmark suffer from a stroke. Treatment for ischemic stroke is available, but only 12% of stroke patients receive it.

The treatment is only available within a time frame of 4,5 hours from symptom onset, thus the Emergency Medical Services (EMS) is essential to fast and effective stroke treatment.

The aim of this study is:

1. To establish the rate of recognition of stroke symptoms by healthcare personnel in the EMD, ultimately aiming at optimizing performance, and identifying barriers for a fast and correct EMS-response.
2. To assess prehospital time consumption by ambulance personnel on the scene of a stroke, create a baseline for future comparison and generate explorative hypotheses for forthcoming interventions.

The overall aim of this study is, to ensure the best possible prehospital care for all stroke patients. The study will determine, if the EMD is at a high and international level in regards to stroke recognition, and if there is a potential to decrease on-scene time. This will serve as future comparison and have an effect on the structure and future education in the prehospital services, and potentially improve the outcome after acute ischemic stroke.

Conditions

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Bispebjerg Hospital

    collaborator OTHER

  • Glostrup University Hospital, Copenhagen

    collaborator OTHER

  • TrygFonden, Denmark

    collaborator INDUSTRY

  • Emergency Medical Services, Capital Region, Denmark

    lead OTHER_GOV

Principal Investigators

  • Freddy Lippert, MD, CEO · Emergency Medical Services, Capital Region, Denmark

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02191514 on ClinicalTrials.gov